ISPOR is the leading scientific and educational organization for HEOR (Health Economics & Outcomes Research) and its use in healthcare decision-making. The ISPOR engages global leaders in the world-wide HEOR community, including policy makers, regulators, researchers, academicians, health technology developers, payers, healthcare providers, and patient groups.
More than 5000 global healthcare leaders attended ISPOR Europe 2019 in an energizing meeting ground for sound science, robust methodology, relevant policy discussions, and multistakeholder perspectives. Some of the trending topics at the conference include: Real-World Evidence,Digital Health,Health Technology Assessment, Machine Learning and Artificial Intelligence, Clinical Outcomes Assessment, Medical Devices , and Value Assessment.
Biohope, at this Conference, presented the Poster: “Economic evaluation of an in vitro diagnostic assay (Immunobiogram) in the selection and dose titration of immunosuppressive therapy (IS) in kidney transplant patients in Spain. “ (Díez T, Portero I, Jimenez C, Crespo M, Portoles JM, Rubio-Terrés C, Rubio-Rodríguez D), The study shows that the routine use of the Immunobiogram© in patients one year after their kidney transplant would reduce the risk of renal graft failure and AEs associated with immunosupressants with considerable savings for the NHS.